MedTrace Logo

Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments

NCT03051347 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 943

Last updated 2020-10-09

No results posted yet for this study

Summary

This is designated to validate patient-reported outcomes (PRO) measures in itch-specific pediatric skin conditions, such as atopic dermatitis, and examine the ability of a modified stigma instrument to assess the severity and type of stigma experienced in atopic dermatitis and other potentially stigmatizing conditions.

Conditions

Interventions

OTHER

Itch Questionnaire and Interview

OTHER

Stigma Questionnaire and Interview

OTHER

Cognitive Interview and PROMIS Itch Questionnaire

Sponsors & Collaborators

Principal Investigators

  • Amy Paller, MD · Northwestern University and Lurie Children's Hospital Department of Dermatology

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
0 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2020-02-09
Completion
2020-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03051347 on ClinicalTrials.gov